Defining a mutational panel and predicting the prevalence of cystic fibrosis in oman.

The Cystic Fibrosis Symptom Progression Survey (CF-SPS) in Arabic: A Tool for Monitoring Patient's Symptoms. Oman Med J (2015) 0.75

MENDELIAN PROPORTIONS IN A MIXED POPULATION. Science (1908) 60.99

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science (1989) 40.22

Identification of the cystic fibrosis gene: genetic analysis. Science (1989) 33.61

Identification of the cystic fibrosis gene: chromosome walking and jumping. Science (1989) 21.46

The genetical structure of populations. Ann Eugen (1951) 15.13

Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med (1998) 5.79

Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening. Hum Mutat (2002) 5.43

Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 4.27

Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet (2013) 2.91

High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr (2004) 2.31

Cystic fibrosis: terminology and diagnostic algorithms. Thorax (2005) 2.08

Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat (1997) 1.69

Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. Genomics (1992) 1.53

A study of consanguinity in the Sultanate of Oman. Ann Hum Biol (2000) 1.49

Respiratory bacterial infections in cystic fibrosis. Curr Opin Pulm Med (2013) 1.28

Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counseling. Fertil Steril (2000) 1.13

Gastrointestinal complications of cystic fibrosis. Clin Gastroenterol Hepatol (2012) 1.06

Cystic fibrosis carrier frequency and estimated prevalence of the disease in Morocco. J Cyst Fibros (2008) 1.00

Heterogeneity of the cystic fibrosis phenotype in a large kindred family in Qatar with cystic fibrosis mutation (I1234V). J Trop Pediatr (2001) 0.97

Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. Hum Genet (1995) 0.92

Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening. Am J Med Genet A (2005) 0.88

Determination of the prevalence of cystic fibrosis in the United Arab Emirates by genetic carrier screening. Clin Genet (1999) 0.88

Identification of cystic fibrosis mutations in the United Arab Emirates. Mutations in brief no. 133. Online. Hum Mutat (1998) 0.87

Cystic Fibrosis testing among Arab-Americans. Genet Med (2006) 0.87

Cystic fibrosis presenting with recurrent vomiting and metabolic alkalosis. Eur J Pediatr (1991) 0.86

Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia. East Mediterr Health J (1999) 0.85

Diagnosing and managing cystic fibrosis in the developing world. Paediatr Respir Rev (2006) 0.82

First report of cystic fibrosis mutations in Libyan cystic fibrosis patients. Ann Hum Biol (2011) 0.80